Compare Stocks

→ Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CCC Clarivate	$0.02	$29.06	$15.00 ▼ $33.55	$12.12M	0.53	1.24 million shs	19,871 shs
SOPH SOPHiA GENETICS	$4.85 -2.6%	$4.87	$2.13 ▼ $7.37	$324.85M	1.17	79,611 shs	150,325 shs

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CCC Clarivate	0.00%	0.00%	0.00%	0.00%	0.00%
SOPH SOPHiA GENETICS	-2.61%	-4.53%	+12.01%	+7.54%	-4.90%

Did You Get Your Free Bitcoin Yet? (Ad)

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CCC Clarivate	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SOPH SOPHiA GENETICS	1.4603 of 5 stars	3.5	3.0	0.0	0.0	1.9	0.0	0.6

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CCC Clarivate	N/A	N/A	N/A	N/A
SOPH SOPHiA GENETICS	3.00	Buy	$8.00	64.95% Upside

Current Analyst Ratings

Latest RSW, CWR, SOPH, and CCC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
3/6/2024	SOPH SOPHiA GENETICS	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$7.00 ➝ $8.00
3/6/2024	SOPH SOPHiA GENETICS	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$8.00

(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CCC Clarivate	$974.34M	0.01	$0.00 per share	29.97	$4.43 per share	0.00
SOPH SOPHiA GENETICS	$62.37M	5.07	N/A	N/A	$3.16 per share	1.53

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CCC Clarivate	-$210.98M	$0.35	N/A	0.03	N/A	-18.75%	7.92%	3.39%	N/A
SOPH SOPHiA GENETICS	-$78.98M	-$1.22	N/A	N/A	N/A	-126.63%	-47.40%	-36.43%	5/14/2024 (Estimated)

Latest RSW, CWR, SOPH, and CCC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/5/2024	12/31/2023	SOPH SOPHiA GENETICS	-$0.25	-$0.37	-$0.12	-$0.37	$16.78 million	$17.05 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CCC Clarivate	N/A	N/A	N/A	N/A	N/A
SOPH SOPHiA GENETICS	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CCC Clarivate	0.81	1.42	1.42
SOPH SOPHiA GENETICS	N/A	4.16	3.97

Ownership

Institutional Ownership

Company	Institutional Ownership
CCC Clarivate	42.83%
SOPH SOPHiA GENETICS	31.59%

Insider Ownership

Company	Insider Ownership
CCC Clarivate	2.32%
SOPH SOPHiA GENETICS	4.88%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CCC Clarivate	4,090	605.96 million	N/A	Not Optionable
SOPH SOPHiA GENETICS	430	65.23 million	62.05 million	Not Optionable

RSW, CWR, SOPH, and CCC Headlines

Source	Headline
	'Shopaholic' author Sophie Kinsella reveals brain cancer diagnosis abcnews.go.com - April 17 at 2:41 PM
	SOPHiA GENETICS SA (NASDAQ:SOPH) Sees Significant Increase in Short Interest americanbankingnews.com - April 15 at 5:40 AM
	Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Expands By 22.3% marketbeat.com - April 13 at 7:47 PM
	RHOC’s Lauri Peterson Shares Glimpse Into ‘Saddest Day of My Life’ After Son Josh Waring’s Death msn.com - April 13 at 6:11 PM
	Leicester girl constantly on sedatives gets 'pacemaker for the brain' msn.com - April 13 at 6:11 PM
	Lauri Peterson Experiences ‘Saddest Day’ After Son Josh Waring’s Death aol.com - April 13 at 1:38 AM
	Emma and other books adapted into both movies and TV shows lifestyleasia.com - April 12 at 8:37 PM
	RBC Capital Sticks to Its Buy Rating for SOPHiA GENETICS (SOPH) markets.businessinsider.com - April 9 at 9:33 AM
	Bill to correct outdated law barring IVF children from inheritance passes committee at eleventh hour enterprise-journal.com - April 4 at 2:09 PM
	SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership prnewswire.com - April 4 at 1:00 AM
	Breast Cancer Outcomes May Be Predicted More Accurately If TILs Serve as Biomarkers genengnews.com - April 3 at 1:46 PM
	Laboratorio Barnafi-Krause is Live on SOPHiA DDM™ prnewswire.com - April 2 at 10:00 AM
	How popular is your dog? These are the top breeds in NJ nj1015.com - March 29 at 2:57 PM
	SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Down 28.6% in March marketbeat.com - March 29 at 12:44 PM
	Americas dengue outbreak is the ‘worst to date’ msn.com - March 28 at 11:54 PM
	A promising discovery in a rare neurodegenerative disease msn.com - March 28 at 11:54 PM
	Women leading the herd in agriculture business examiner.com.au - March 28 at 11:54 PM
	Discovering the Hidden Science of Everyday Wonders msn.com - March 28 at 11:54 PM
	USask and Sophia Genetics partner to improve ovarian cancer trial msn.com - March 21 at 6:24 PM
	SOPHiA GENETICS and the French Kidney Cancer Research Network publish results from multiyear collaboration pharmabiz.com - March 18 at 9:49 AM
	Teen of the Week: Parkersburg Catholic junior Sophia D’Eramo looks forward to career in medical field newsandsentinel.com - March 16 at 10:21 AM
	SOPHiA GENETICS Logo (IMAGE) eurekalert.org - March 15 at 10:54 PM
	Radiation Paradox: Scientists Discover Nematodes Thriving in Chernobyl’s Toxic Landscape scitechdaily.com - March 15 at 12:53 PM
	SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration finance.yahoo.com - March 15 at 7:53 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Clarivate

NYSE:CCC

Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.

SOPHiA GENETICS

NASDAQ:SOPH

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial